For: | Liu YQ, Poon RT, Hughes J, Li QY, Yu WC, Fan ST. Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma. World J Gastroenterol 2005; 11(2): 164-170 [PMID: 15633209 DOI: 10.3748/wjg.v11.i2.164] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i2/164.htm |
Number | Citing Articles |
1 |
Maw-Soan Soon, Anny Soon, Tin-Yu Lin, Otto S. Lin. Distribution of colon neoplasia in Chinese patients: implications for endoscopic screening strategies. European Journal of Gastroenterology & Hepatology 2008; 20(7): 642 doi: 10.1097/MEG.0b013e3282f6482b
|
2 |
Emilie Viey, Claire Lucas, François Romagne, Bernard Escudier, Salem Chouaib, Anne Caignard. Chemokine Receptors Expression and Migration Potential of Tumor-infiltrating and Peripheral-expanded Vγ9Vδ2 T Cells From Renal Cell Carcinoma Patients. Journal of Immunotherapy 2008; 31(3): 313 doi: 10.1097/CJI.0b013e3181609988
|
3 |
Chun-Min Liang, Long Chen, Heng Hu, Hui-Ying Ma, Ling-Ling Gao, Jie Qin, Cui-Ping Zhong. Chemokines and their receptors play important roles in the development of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(10): 1390-1402 doi: 10.4254/wjh.v7.i10.1390
|
4 |
Ori Wald, Ido D. Weiss, Eithan Galun, Amnon Peled. Chemokines in hepatitis C virus infection: Pathogenesis, prognosis and therapeutics. Cytokine 2007; 39(1): 50 doi: 10.1016/j.cyto.2007.05.013
|
5 |
Ida Louise Heiberg, Thilde Nordmann Winther, Søren Riis Paludan, Birthe Hogh. Pattern recognition receptor responses in children with chronic hepatitis B virus infection. Journal of Clinical Virology 2012; 54(3): 229 doi: 10.1016/j.jcv.2012.04.013
|
6 |
Birgit Mosch, Doreen Pietzsch, Jens Pietzsch. Irradiation affects cellular properties and Eph receptor expression in human melanoma cells. Cell Adhesion & Migration 2012; 6(2): 113 doi: 10.4161/cam.20655
|
7 |
Hitomi Takada, Koji Yamashita, Leona Osawa, Yasuyuki Komiyama, Natsuko Nakakuki, Masaru Muraoka, Yuichiro Suzuki, Mitsuaki Sato, Shoji Kobayashi, Takashi Yoshida, Shinichi Takano, Shinya Maekawa, Nobuyuki Enomoto. Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma. Oncology 2023; 101(10): 655 doi: 10.1159/000531689
|
8 |
Thjon J. Tang, Dragica Vukosavljevic, Harry L.A. Janssen, Rekha S. Binda, Shanta Mancham, Hugo W. Tilanus, Jan N.M. IJzermans, Hemmo Drexhage, Jaap Kwekkeboom. Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma. Human Pathology 2006; 37(3): 332 doi: 10.1016/j.humpath.2005.11.007
|
9 |
René E. Vasquez, Lijun Xin, Lynn Soong. Effects of CXCL10 on Dendritic Cell and CD4+T-Cell Functions duringLeishmania amazonensisInfection. Infection and Immunity 2008; 76(1): 161 doi: 10.1128/IAI.00825-07
|
10 |
Rajesh K Sharma, Zinal S Chheda, Venkatakrishna R Jala, Bodduluri Haribabu. Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy. Expert Review of Vaccines 2015; 14(4): 537 doi: 10.1586/14760584.2015.982101
|
11 |
Caian L. Vinhaes, Luís A. B. Cruz, Rodrigo C. Menezes, Thomas A. Carmo, María B. Arriaga, Artur T. L. Queiroz, Manoel Barral-Netto, Bruno B. Andrade. Chronic Hepatitis B Infection Is Associated with Increased Molecular Degree of Inflammatory Perturbation in Peripheral Blood. Viruses 2020; 12(8): 864 doi: 10.3390/v12080864
|
12 |
Steven M. Dubinett, Jay M. Lee, Sherven Sharma, James J. Mulé. Chemokines. The Cancer Journal 2010; 16(4): 325 doi: 10.1097/PPO.0b013e3181eb33bc
|
13 |
Chiara Dell’Agnola, Arya Biragyn. Clinical utilization of chemokines to combat cancer: the double-edged sword. Expert Review of Vaccines 2007; 6(2): 267 doi: 10.1586/14760584.6.2.267
|
14 |
Ken Shirabe, Takashi Motomura, Jun Muto, Takeo Toshima, Rumi Matono, Yohei Mano, Kazuki Takeishi, Hideki Ijichi, Noboru Harada, Hideaki Uchiyama, Tomoharu Yoshizumi, Akinobu Taketomi, Yoshihiko Maehara. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management. International Journal of Clinical Oncology 2010; 15(6): 552 doi: 10.1007/s10147-010-0131-0
|
15 |
Martin F. Sprinzl, Peter R. Galle. Immune Control in Hepatocellular Carcinoma Development and Progression: Role of Stromal Cells. Seminars in Liver Disease 2014; 34(04): 376 doi: 10.1055/s-0034-1394138
|
16 |
Federica Barbieri, Adriana Bajetto, Tullio Florio. Role of Chemokine Network in the Development and Progression of Ovarian Cancer: A Potential Novel Pharmacological Target. Journal of Oncology 2010; 2010: 1 doi: 10.1155/2010/426956
|
17 |
Karin Jöhrer, Lisa Pleyer, Angelika Olivier, Eva Maizner, Claudia Zelle-Rieser, Richard Greil. Tumour-immune cell interactions modulated by chemokines. Expert Opinion on Biological Therapy 2008; 8(3): 269 doi: 10.1517/14712598.8.3.269
|
18 |
Xiongfeng Pan, Atipatsa C Kaminga, Shi Wu Wen, Aizhong Liu. Chemokines in hepatocellular carcinoma: a meta-analysis. Carcinogenesis 2020; 41(12): 1682 doi: 10.1093/carcin/bgaa106
|
19 |
Xing-qi Li, Zhi-gang Ouyang, Sheng-hua Zhang, Hong Liu, Yue Shang, Yi Li, Yong-su Zhen. Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin. Cancer Biology & Therapy 2014; 15(4): 398 doi: 10.4161/cbt.27626
|
20 |
Krishnendu Chakraborty, Anamika Bose, Smarajit Pal, Utpala Chattopadhyay, Rathindranath Baral. Interferon-α2b Restores the Impaired Chemotactic Activity of Peripheral Blood Mononuclear Cells from Head and Neck Squamous Cell Carcinoma Patients by Modulating CXC Receptor Ligand Interaction. Journal of Interferon & Cytokine Research 2008; 28(8): 487 doi: 10.1089/jir.2008.0001
|
21 |
Karla J. Helbig, Andrew Ruszkiewicz, Robert E. Lanford, Mark D. Berzsenyi, Hugh A. Harley, Shaun R. McColl, Michael R. Beard. Differential Expression of the CXCR3 Ligands in Chronic Hepatitis C Virus (HCV) Infection and Their Modulation by HCV In Vitro. Journal of Virology 2009; 83(2): 836 doi: 10.1128/JVI.01388-08
|
22 |
M Michailidou, IN Melas, DE Messinis, S Klamt, LG Alexopoulos, FN Kolisis, H Loutrari. Network-Based Analysis of Nutraceuticals in Human Hepatocellular Carcinomas Reveals Mechanisms of Chemopreventive Action. CPT: Pharmacometrics & Systems Pharmacology 2015; 4(6): 350 doi: 10.1002/psp4.40
|
23 |
Anthony T. Reder, Sharlene Velichko, Ken D. Yamaguchi, Kemal Hamamcioglu, Karin Ku, Johanna Beekman, T. Charis Wagner, H. Daniel Perez, Hugh Salamon, Ed Croze. IFN-β1b Induces Transient and Variable Gene Expression in Relapsing-Remitting Multiple Sclerosis Patients Independent of Neutralizing Antibodies or Changes in IFN Receptor RNA Expression. Journal of Interferon & Cytokine Research 2008; 28(5): 317 doi: 10.1089/jir.2007.0131
|
24 |
Krishnendu Chakraborty, Anamika Bose, Smarajit Pal, Koustav Sarkar, Shyamal Goswami, Diptendu Ghosh, Subrata Laskar, Utpala Chattopadhyay, Rathindranath Baral. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance. International Immunopharmacology 2008; 8(2): 330 doi: 10.1016/j.intimp.2007.10.015
|
25 |
Jacqueline Estevez, Vincent L. Chen, Ondrej Podlaha, Biao Li, An Le, Philip Vutien, Ellen T. Chang, Yael Rosenberg-Hasson, Zhaoshi Jiang, Stefan Pflanz, Dongliang Ge, Anuj Gaggar, Mindie H. Nguyen. Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11975-7
|